Top of this page
Skip navigation, go straight to the content

 
image description

Kim Moran

Head of U.S. Insights to Impact

 

Kim Moran is Head of Insights to Impact at UCB. In this role she leads a team across finance, strategy, and operations to leverage insights and align our resources to have the greatest impact for patients. Drawing on her training as a neuroscientist and ten years of pharma industry business experience, she is committed to ensuring UCB delivers maximum value to the patients we serve.

Kim previously served as Head of Neurology Strategy in the U.S. and Head, Epilepsy Portfolio Strategy & Evolution within the Seizure Freedom Patient Value Mission. She collaborated across the PVU to uncover patient and caregiver insights and translate them into product and program innovations that increase value to those suffering from seizure disorders and solidify UCB’s leadership position in epilepsy.   

Prior to joining the Mission, Kim was Mission Lead for brivaracetam (BRV) lifecycle and medical affairs, where she was responsible for developing both the medical affairs launch plan and the BRV lifecycle management plan drawing on insight-driven, patient-value based principles. Before that she was Mission Lead for Neupro Restless Legs Syndrome (RLS) lifecycle management, and pioneered an innovative platform that used increased awareness of comorbidities in RLS to drive changes in the prevailing treatment paradigms.

Kim holds a Ph.D. in neuroscience and physiology from New York University and a BS in biochemistry and molecular biology from Penn State University. She also held a predoctoral fellowship from the National Science Foundation at the New York University Sackler Institute of Biomedical Sciences where she led research on brain imaging in Parkinson’s disease and the electrophysiology of synaptic vesicle proteins. She is author of nine published articles relating to neurology and more than 40 posters and abstracts.

She started in the pharmaceutical industry as Regional Medical Liaison at Aspreva Pharmaceuticals where she provided pre-launch support to Cellcept (mycophenolate mofetil) in Lupus nephritis and Myasthenia Gravis.

She lives in Marietta, Georgia with her husband and two children.


Download Bio